Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00059887.xml

CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807996
DOI: 10.1055/s-0045-1807996
SKIN TUMORS
2027
POSTER PRESENTATION
Lactate dehydrogenase as an independent prognostic factor for survival in patients with advanced melanoma treated with immune checkpoint blockade
Authors
Publication History
Article published online:
06 May 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Marcos Rezende de Jesus Teixeira, Milton Jose de Barros, Joao Duprat, Joao Paulo de Sousa Barreira Mascarenhas, Leticia Barbosa Ferro Pace, Alessandra Thomé Espada, Gustavo Alberto Fischer Marinho, Débora Quioqueti de Souza Franco, Agatha Cabral Zeidan, Rahianni Baldaia Vilas Boas Sampaio, Geovanna Gabrielly dos Santos Silva, Julle Emerson Nogueira Silva Júnior, Luiz Antônio Perazolo Carolo, Gabriela Midding Rocha, José Inácio da Costa Lima Rodrigues. Lactate dehydrogenase as an independent prognostic factor for survival in patients with advanced melanoma treated with immune checkpoint blockade. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807996
Marcos Rezende de Jesus Teixeira, Milton Jose de Barros, Joao Duprat, Joao Paulo de Sousa Barreira Mascarenhas, Leticia Barbosa Ferro Pace, Alessandra Thomé Espada, Gustavo Alberto Fischer Marinho, Débora Quioqueti de Souza Franco, Agatha Cabral Zeidan, Rahianni Baldaia Vilas Boas Sampaio, Geovanna Gabrielly dos Santos Silva, Julle Emerson Nogueira Silva Júnior, Luiz Antônio Perazolo Carolo, Gabriela Midding Rocha, José Inácio da Costa Lima Rodrigues. Lactate dehydrogenase as an independent prognostic factor for survival in patients with advanced melanoma treated with immune checkpoint blockade. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807996